Many primary care professionals manage injection or infusion therapies in patients with
diabetes. Few published guidelines have been available to help such professionals and …

Variability in the effect of subcutaneously administered insulin represents a major challenge
in insulin therapy where precise dosing is required in order to achieve targeted glucose …

The aim of this randomized double-blind study was to compare the within-subject variability
of the glucose-lowering effect of a novel insulin analog, insulin detemir, with that of insulin …

Objective: During subcutaneous insulin therapy, inadvertent intramuscular (IM) injections
may increase pain and/or adversely affect glucose control. The most appropriate needle …

AIM: Injections administered by patients are one of the mainstays of diabetes management.
Proper injection technique is vital to avoiding intramuscular injections, ensuring appropriate …

Subcutaneous (sc) injections of identical insulin doses may lead to considerable intra-and
inter-individual differences in the current metabolic control of patients with diabetes mellitus …

Abstract From February 1, 2014, through June 30, 2015, 13,289 insulin-injecting patients
from 423 centers in 42 countries took part in one of the largest surveys ever performed in …

OBJECTIVE: To compare the efficacy of 2 intensified insulin regimens, continuous
subcutaneous insulin infusion (CSII) and multiple daily injections (MDI), by using the short …

Настоящее издание-дополненная и существенно переработанная версия клинических
рекомендаций, опубликованных в предыдущие годы, содержит информацию о …

The therapeutic goal in insulin-treated diabetic patients is to maintain on the long-term a
tight glucose control (HbA1c< 6, 5-7% or less) through an insulin regimen which “mimic” the …